Colorado State University donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Facebook page coloradostateuniversity
Websitehttp://www.colostate.edu/
Twitter usernamecoloradostateu
Wikipedia pagehttps://en.wikipedia.org/wiki/Colorado_State_University
Instagram usernamecoloradostateuniversity

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 58 109,828 376,601 -2,800 -157 -28 44,000 100,000 109,828 200,000 253,684 678,939 1,101,761 2,599,996
Global health 42 100,000 411,246 -2,800 -176 -91 -5 50,000 100,000 208,591 593,628 679,634 1,101,761 2,599,996
10 200,000 381,086 20,000 20,000 25,000 100,533 109,828 200,000 200,000 200,000 200,000 1,055,500 1,700,000
Working Longer 1 20,000 20,000 20,000 20,000 20,000 20,000 20,000 20,000 20,000 20,000 20,000 20,000 20,000
FIXME 3 75,000 128,662 75,000 75,000 75,000 75,000 75,000 75,000 75,000 235,987 235,987 235,987 235,987
Nutrition 1 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000
Science 1 253,684 253,684 253,684 253,684 253,684 253,684 253,684 253,684 253,684 253,684 253,684 253,684 253,684

Donation amounts by donor and year for donee Colorado State University

Donor Total 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2001 1999 1988
Bill and Melinda Gates Foundation (filter this donee) 17,372,332.21 0.00 120,640.38 -526.31 2,810,641.74 2,155,224.00 1,456,098.00 1,200,758.59 3,478,903.81 200,000.00 900,451.00 1,348,384.00 3,701,757.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Walton Family Foundation (filter this donee) 2,755,361.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100,533.00 25,000.00 109,828.00 20,000.00 200,000.00 200,000.00 200,000.00 200,000.00 1,700,000.00 0.00 0.00 0.00
W. K. Kellogg Foundation (filter this donee) 1,055,500.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,055,500.00
Sloan Foundation (filter this donee) 273,684.00 253,684.00 0.00 0.00 0.00 20,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Ford Foundation (filter this donee) 235,987.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 235,987.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
MacArthur Foundation (filter this donee) 150,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 75,000.00 75,000.00 0.00
Total 21,842,864.21 253,684.00 120,640.38 -526.31 2,810,641.74 2,175,224.00 1,456,098.00 1,200,758.59 3,579,436.81 225,000.00 1,246,266.00 1,368,384.00 3,901,757.00 200,000.00 200,000.00 200,000.00 1,700,000.00 75,000.00 75,000.00 1,055,500.00

Full list of donations in reverse chronological order (58 donations)

DonorAmount (current USD)Amount rank (out of 58)Donation dateCause areaURLInfluencerNotes
Sloan Foundation253,684.00412018Science/Chemistry of Indoor Environmentshttps://sloan.org/grant-detail/8578-- Grant investigator: Delphine Farmer; to develop and test software to identify isomers based on differences in binding energy using time-of-flight chemical ionization mass spectrometry.
Bill and Melinda Gates Foundation121,021.00302017-10-09Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to promote the development of new antibiotics for the treatment of tuberculosis and other mycobacterial diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-85.58102017-08-11Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to block residual malaria transmission by vaccinating cattle with selected, essential antigens from the mosquito Anopheles so that they produce antibodies that are lethal to the mosquitoes that feed on them.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-91.3892017-01-30Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-27.56122017-01-25Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-176.1052017-01-06Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a novel approach and series of biomarkers for the diagnosis of tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-157.0162016-07-25Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-157.0162016-07-25Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-152.0882016-04-12Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to evaluate the metabolic status of host granulomatous tissue and TB during drug treatment and disease relapse in the mouse model of TB and during disease progression in the mouse and non-human primate models of TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-60.21112016-02-25Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop methods to detect specific volatile organic compound (VOCs) signatures in Mycobacterium tuberculosis infected guinea pigs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,320,307.00572015-10-16Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to enable the discovery and development of more effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00232015-10-09Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to block residual malaria transmission by vaccinating cattle with selected, essential antigens from the mosquito Anopheles so that they produce antibodies that are lethal to the mosquitoes that feed on them.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation44,000.00182015-10-02Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to test the effects of dietary rice bran and rice varietal differences in bacterial and viral pathogen disease prevention models; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-5.26132015-09-28Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to facilitate a guinea pig natural transmission study, further the development of this natural transmission model, and establish cell based assays to detect M. tuberculosis infection regardless of vaccination status; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation137,749.00312015-06-01Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation208,591.00382015-03-24Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to enable the discovery and development of more effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation50,000.00192014-10-06Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation50,000.00192014-10-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation678,939.00472014-07-21Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation540,187.00422014-04-28Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a novel approach and series of biomarkers for the diagnosis of tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation591,185.00432014-04-21Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation244,913.00402014-02-18Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop methods to detect specific volatile organic compound (VOCs) signatures in Mycobacterium tuberculosis infected guinea pigs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Sloan Foundation20,000.00142014Working Longer/https://sloan.org/grant-detail/7007-- Grant investigator: Gwenith Fisher; to analyze data from the Health and Retirement Study and the Occupational Information Network to study novel research questions regarding workers’ perceptions of their work ability or job-related capacity and labor force participation among older workers.
Bill and Melinda Gates Foundation862,470.00492013-07-29Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to determine the ability of high transmission strains of tuberculosis to grow in the relevant guinea pig small animal model; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation593,628.00442013-02-01Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to facilitate a guinea pig natural transmission study, further the development of this natural transmission model, and establish cell based assays to detect M. tuberculosis infection regardless of vaccination status; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation206,422.00372012-10-29Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,000,000.00502012-05-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to test the effects of dietary rice bran and rice varietal differences in bacterial and viral pathogen disease prevention models; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-2,678.0022012-01-27Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to support a discussion of what can be learned from the successes and failures of BCG and how this can be applied to the development of more effective vaccines against TB.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-2,800.0012012-01-10Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to define the in vivo physiology of Mycobacterium tuberculosis and implement methods to asses metabolites found in M. tuberculosis infected tissue; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-185.4142012-01-03Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop non-invasive phage particle based sensors for active tuberculosis. Non-Invasive Phage Particle Based Sensors for Active TB. Investment start date: 5/1/2010 to end date: 10/31/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,005,773.00512011-10-31Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to evaluate the metabolic status of host granulomatous tissue and TB during drug treatment and disease relapse in the mouse model of TB and during disease progression in the mouse and non-human primate models of TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,173,007.00542011-10-24Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation600,597.00462011-10-17Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a novel approach and series of biomarkers for the diagnosis of tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation679,634.00482011-10-17Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation21,120.00162011-07-13Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to support a discussion of what can be learned from the successes and failures of BCG and how this can be applied to the development of more effective vaccines against TB.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-1,227.1932011-04-07Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to research whether providing endectocides, drugs that kill parasitic worms, to animals and humans will effectively kill mosquitoes which feed on them; Aid type: Project-type interventions. Affected regions: South of Sahara.
Walton Family Foundation100,533.00282011--http://conservativetransparency.org/donor/walton-family-foundation--
Bill and Melinda Gates Foundation100,000.00232010-04-05Nutrition/basic nutritionhttps://iatiregistry.org/publisher/bmgf-- to screen a diverse, global set of rice varieties to identify bioactive components in the bran that augment mucosal immunity against enteric bacterial pathogens; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00232010-04-02Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop non-invasive phage particle based sensors for active tuberculosis. Non-Invasive Phage Particle Based Sensors for Active TB. Investment start date: 5/1/2010 to end date: 10/31/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Walton Family Foundation25,000.00172010--http://conservativetransparency.org/donor/walton-family-foundation--
Bill and Melinda Gates Foundation600,009.00452009-09-21Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to define the in vivo physiology of Mycobacterium tuberculosis and implement methods to asses metabolites found in M. tuberculosis infected tissue; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation200,442.00362009-09-08Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to provide standardized models for Tuberculosis drug discovery. TB Assay Standardization. Investment start date: 10/1/2007 to end date: 9/30/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00232009-02-26Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a novel arthropod-based vaccine system against leishmaniasis. Novel arthropod-based vaccine system against leishmaniasis.. Investment start date: 5/1/2009 to end date: 10/31/2010. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Ford Foundation235,987.00392009-02-01FIXMEhttp://www.fordfoundation.org/work/our-grants/grants-database/grants-all-- For the Warner College of Natural Resources and Chinese and Mongolian stakeholders to prepare case studies and policy recommendations on participatory rangeland management and climate adaptation. Affected regions: 103###Beijing Municipality###30@@@448###Inner Mongolia###30@@@647###Mongolia###20@@@1115###Xinjiang###20; 9177417###Female@@@9177418###Male@@@9177887###Racial ethnic minority; China; affected countries: FIXME.
Walton Family Foundation109,828.00292009--http://conservativetransparency.org/donor/walton-family-foundation--
Bill and Melinda Gates Foundation100,000.00232008-10-10Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to research whether providing endectocides, drugs that kill parasitic worms, to animals and humans will effectively kill mosquitoes which feed on them; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation1,248,384.00552008-08-01Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to study the basis of why a small number of tuberculosis bacteria still persist in vivo after drug therapy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Walton Family Foundation20,000.00142008--http://conservativetransparency.org/donor/walton-family-foundation--
Bill and Melinda Gates Foundation1,101,761.00532007-09-12Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to provide standardized models for Tuberculosis drug discovery. TB Assay Standardization. Investment start date: 10/1/2007 to end date: 9/30/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,599,996.00582007-09-12Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to define the in vivo physiology of Mycobacterium tuberculosis and implement methods to asses metabolites found in M. tuberculosis infected tissue; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Walton Family Foundation200,000.00322007--http://conservativetransparency.org/donor/walton-family-foundation--
Walton Family Foundation200,000.00322006--http://conservativetransparency.org/donor/walton-family-foundation--
Walton Family Foundation200,000.00322005--http://conservativetransparency.org/donor/walton-family-foundation--
Walton Family Foundation200,000.00322004--http://conservativetransparency.org/donor/walton-family-foundation--
Walton Family Foundation1,700,000.00562003--http://conservativetransparency.org/donor/walton-family-foundation--
MacArthur Foundation75,000.00212001FIXMEhttps://www.macfound.org/grants/-- For "Fair Trade: Creating an Alternative Global Food System.". Affected countries: United States; affected states: Colorado; affected cities: Fort Collins.
MacArthur Foundation75,000.00211999FIXMEhttps://www.macfound.org/grants/-- To support the research project Re-Regulating the Global Economy through Fair Trade: Setting a Research Agenda. Affected countries: United States; affected states: Colorado; affected cities: Fort Collins.
W. K. Kellogg Foundation1,055,500.00521988-06-01--https://www.wkkf.org:443/grants/grant/1990/01/upma0002c-0001241-- Purpose: Revitalize small rural communities through leadership development; Grant period: 1988-06-01 to 1991-11-30. Affected countries: United States; affected states: Colorado.